Target intelligence / Profile preview

Non-P4HA3 mRNAs with seed-region complementarity

Molecular classification
Messenger RNA
01

Overview

Non-P4HA3 mRNAs with seed-region complementarity refers to a collective group of messenger RNA (mRNA) transcripts that are potential off-targets for RNA interference (RNAi) therapies designed to inhibit Prolyl 4-hydroxylase subunit alpha 3 (P4HA3). P4HA3 is a key enzyme in collagen synthesis, often overexpressed in the tumor microenvironment and associated with poor prognosis in various cancers (UniProt P59813). The specificity of RNAi-based drugs, such as siRNAs, is largely determined by the seed region, a 6-8 nucleotide sequence that guides the RNA-induced silencing complex (RISC) to its target. When transcripts other than P4HA3 share complementarity with this seed sequence, they may undergo unintended degradation or translational repression (Jackson et al., 2003, Nature Biotechnology). This phenomenon poses a significant challenge in drug development, as silencing these non-target mRNAs can lead to off-target effects and associated cellular toxicity (Birmingham et al., 2006, Nature Methods). Consequently, these mRNAs are not therapeutic targets themselves but are critical variables in the safety assessment of P4HA3-directed oligonucleotides. Identifying and minimizing interactions with these transcripts is essential for ensuring the precision and safety of gene-silencing interventions.

Other names
P4HA3 siRNA off-targetsSeed-matched non-target transcriptsOff-target mRNAs
02

Mechanism of action

RNA interference (RNAi) mediated gene silencing

03

Biological functions

Protein synthesisGene expression regulation
04

Disease associations

Off-target toxicityUnintended gene silencing
05

Safety considerations

Unintended gene knockdownOff-target toxicityCellular dysfunctionLoss of essential protein function
06

Interacting drugs

P4HA3-targeted siRNA

1 more in the full profile.

07

Biomarkers

RNA-seqDifferential gene expression analysisTranscriptome profiling

Beyond the preview

Go deeper on Non-P4HA3 mRNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-P4HA3 mRNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call